Mon-20-03-2017, 15:55 PM
(Mon-20-03-2017, 15:34 PM)Caroline Wrote: I share your concerns, but like Jim I think new deals will be made. Will they be better or worse that is the question.
For the DMF it will even be broader available. USA has their Tecf*dera, but that is too costly to use for Psoriasis.
But from Spains Almirall a new one will come, and probably in the price range of Fumaderm. They might also export too. Europe or even to the USA. The last would be interesting.
For the Netherlands Psorinovo is produced in the Netherlands itself, so unless some stupid regulation ends that, some Pharma would like that, it will stay being produced.
I'm not so much concerned more curious as like you say deals will be done and for me personally as Novartis is a Swiss company I don't see a problem continuing to get Cosentyx in France as both countries already have a good relationship. The problem that could arise would be if indeed my Cosentyx is made in the UK as I think it is I can see some problems for Novartis (who are after all said and done only in it for the money)
As for Almirral wouldn't they have to abide by the EU rules of trade of LAS41008 to the UK and USA and to possible new tariffs on imports in those countries?
I'm sure the governments and companies will find a way around these problems as they need each other, but it could cause some disruption for new treatments or even possible withdrawal of some psoriasis treatments in different countries.